ArticleJournal of fluorescence2009
Study and application of the interaction between asymmetrical porphyrin and ascorbic acid.
Article in Journal of fluorescence, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 4 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The interaction between novel asymmetrical porphyrin 5,10,15-triphenyl-20-pyridyl porphyrin and ascorbic acid has been studied by fluorophotometry. It has been found experimentally that in the presence of CTMAB micro-emulsion, the absorption and fluorescence intensity of the porphyrin was greatly enhanced. The addition of ascorbic acid caused the decrease of the intensity, and there was a linear relationship between the fluorescence quenching value and the concentration of ascorbic acid in certain extent. Based on this phenomenon, a new fluorescence quenching method for the determination of ascorbic acid was established, and utilized in the determination of commercial tablets with satisfactory results. The quenching mechanism between porphyrin and ascorbic acid was preliminary studied, and the quenching was belonging to static quenching.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.